Beduya, Jocelyn S.
HRN: 24-19-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/05/2023
CEFUROXIME 500MG (TAB)
12/05/2023
12/12/2023
PO
500 Mg
BID
PROM; SECOND DEGREE EPISIOTOMY
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary TractReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes